Mycobacterium tuberculosis Strains H37ra and H37rv have equivalent minimum inhibitory concentrations to most antituberculosis drugs
Background: Mycobacterium tuberculosis (Mtb) strains H37Ra and H37Rv are commonly used to study new and re-evaluate old antituberculous agents with respect to their pharmacodynamic effects in vitro. The differences in membrane proteins and, in particular, differences in carrier proteins between Mtb...
Main Authors: | Marc Tobias Heinrichs, Robert Justin May, Fabian Heider, Tobias Reimers, Sherwin Kenneth B. Sy, Charles Arthur Peloquin, Hartmut Derendorf |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | International Journal of Mycobacteriology |
Subjects: | |
Online Access: | http://www.ijmyco.org/article.asp?issn=2212-5531;year=2018;volume=7;issue=2;spage=156;epage=161;aulast=Heinrichs |
Similar Items
-
In Silico Approach: Anti-Tuberculosis Activity of Caespitate in the H37Rv Strain
by: Andrea Moreno-Ceballos, et al.
Published: (2024-06-01) -
The new attenuated strain of <i>Mycobacterium tuberculosis</i> BN. Characteristics and vaccine properties
by: B. V. Nikonenko, et al.
Published: (2021-11-01) -
Identification of region of difference and H37Rv-related deletion in Mycobacterium tuberculosis complex by structural variant detection and genome assembly
by: Zhuochong Liu, et al.
Published: (2022-09-01) -
MONOPHENOL TS-13 improves SURVIVAL in MICE INFECTed with VIRULENT <i>M</i><i>ycobacterium tuberculosis</i>
by: P. M. Kozhin, et al.
Published: (2019-02-01) -
PRECLINICAL STUDIES OF THE SPECIFIC ACTIVITY OF THE NEW ANTITUBERCULOSIS DRUG THIOZONIDE
by: I. V. Bocharova, et al.
Published: (2014-06-01)